Vest Financial LLC Has $46.10 Million Holdings in The Clorox Company $CLX

Vest Financial LLC boosted its stake in shares of The Clorox Company (NYSE:CLX) by 13.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 383,962 shares of the company’s stock after buying an additional 45,773 shares during the period. Vest Financial LLC’s holdings in Clorox were worth $46,102,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of CLX. Park Avenue Securities LLC bought a new stake in shares of Clorox in the 1st quarter valued at approximately $258,000. Wealthcare Advisory Partners LLC grew its stake in shares of Clorox by 47.8% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 2,350 shares of the company’s stock valued at $346,000 after buying an additional 760 shares in the last quarter. Fifth Third Bancorp grew its stake in shares of Clorox by 5.7% in the 1st quarter. Fifth Third Bancorp now owns 4,778 shares of the company’s stock valued at $704,000 after buying an additional 259 shares in the last quarter. NorthCrest Asset Manangement LLC grew its stake in shares of Clorox by 67.9% in the 1st quarter. NorthCrest Asset Manangement LLC now owns 3,535 shares of the company’s stock valued at $521,000 after buying an additional 1,430 shares in the last quarter. Finally, Everhart Financial Group Inc. grew its stake in shares of Clorox by 6.4% in the 1st quarter. Everhart Financial Group Inc. now owns 2,718 shares of the company’s stock valued at $400,000 after buying an additional 163 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 0.1%

CLX opened at $120.14 on Monday. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market capitalization of $14.63 billion, a price-to-earnings ratio of 18.43, a P/E/G ratio of 0.98 and a beta of 0.52. The business has a 50 day moving average of $122.21 and a 200-day moving average of $128.57.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the prior year, the business earned $1.82 earnings per share. Clorox’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio is currently 76.07%.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.57% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Clorox in a research report on Saturday, September 27th. Wells Fargo & Company decreased their target price on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research report on Thursday, September 25th. Jefferies Financial Group decreased their target price on Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research report on Thursday, June 26th. The Goldman Sachs Group decreased their target price on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. Finally, JPMorgan Chase & Co. decreased their target price on Clorox from $135.00 to $127.00 and set a “neutral” rating for the company in a research report on Friday. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, Clorox currently has an average rating of “Reduce” and a consensus price target of $131.92.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.